[go: up one dir, main page]

BG105204A - Salts of paroxetine - Google Patents

Salts of paroxetine

Info

Publication number
BG105204A
BG105204A BG105204A BG10520401A BG105204A BG 105204 A BG105204 A BG 105204A BG 105204 A BG105204 A BG 105204A BG 10520401 A BG10520401 A BG 10520401A BG 105204 A BG105204 A BG 105204A
Authority
BG
Bulgaria
Prior art keywords
paroxetine
salts
peperidine
therapy
preparing
Prior art date
Application number
BG105204A
Other languages
Bulgarian (bg)
Inventor
Victor JACEWICZ
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105204A publication Critical patent/BG105204A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Peperidine compounds, processes for preparing them, pharmaceutical compositions comprising them and their use in therapy are disclosed. 11 claims
BG105204A 1998-07-02 2001-01-31 Salts of paroxetine BG105204A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (1)

Publication Number Publication Date
BG105204A true BG105204A (en) 2001-11-30

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105204A BG105204A (en) 1998-07-02 2001-01-31 Salts of paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1622630T3 (en) 2003-05-07 2013-01-31 Osteologix As Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
DK1534305T3 (en) 2003-05-07 2007-02-05 Osteologix As Treatment of cartilage / bone disorders with water-soluble strontium salts
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
CA2565840A1 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) * 2004-09-21 2007-01-19 주식회사종근당 Choline or Choline Derivative Salts of Paroxetine
CA2672267C (en) 2006-07-27 2016-05-31 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof
US12172966B1 (en) 2023-09-15 2024-12-24 King Faisal University 2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
ATE200781T1 (en) * 1997-06-10 2001-05-15 Synthon Bv 4-PHENYLPIPERIDINE DERIVATIVES
KR20010040711A (en) * 1998-02-06 2001-05-15 피터 기딩스 Salts of Paroxetine

Also Published As

Publication number Publication date
EA200100098A1 (en) 2001-08-27
IL140385A0 (en) 2002-02-10
BR9911679A (en) 2002-01-29
SK20242000A3 (en) 2001-07-10
NO20006547L (en) 2001-02-12
AP2000002017A0 (en) 2000-12-31
CA2336470A1 (en) 2000-01-13
PL345365A1 (en) 2001-12-17
WO2000001692A1 (en) 2000-01-13
HUP0103712A2 (en) 2002-05-29
ZA992899B (en) 2000-03-29
CZ20004923A3 (en) 2001-08-15
KR20010053337A (en) 2001-06-25
AU4903999A (en) 2000-01-24
EP1091958A1 (en) 2001-04-18
TR200100055T2 (en) 2001-07-23
GB9814316D0 (en) 1998-09-02
ID27766A (en) 2001-04-26
NO20006547D0 (en) 2000-12-21
CN1314906A (en) 2001-09-26
ZA200100020B (en) 2002-03-25
HUP0103712A3 (en) 2002-09-30
AU2002100370A4 (en) 2002-06-06
JP2002519421A (en) 2002-07-02

Similar Documents

Publication Publication Date Title
ES2158778A1 (en) Paroxetine methanesulfonate
SE9704546D0 (en) Novel compounds
EE200000320A (en) Novel compounds
SE9704544D0 (en) Novel compounds
MY125978A (en) Admantane derivatives
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
MX9700082A (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide.
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
IL150201A0 (en) Novel piperidine and piperazine derivatives
BG64475B1 (en) Ziprasidone salts
IL149154A0 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
SE9802937D0 (en) Novel compounds
HUP0100336A3 (en) Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them
BG105204A (en) Salts of paroxetine
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
EP1059304A4 (en) Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
YU46302A (en) Substituted pyrroles
HUP0200412A3 (en) New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use
DK1165596T3 (en) 14,15-alpha-methylene-equilenin derivatives, process for their preparation and drugs containing them